Literature DB >> 18577502

Tuberculosis reinfection rate as a proportion of total infection rate correlates with the logarithm of the incidence rate: a mathematical model.

Pieter W Uys1, Paul D van Helden, John W Hargrove.   

Abstract

In a significant number of instances, an episode of tuberculosis can be attributed to a reinfection event. Because reinfection is more likely in high incidence regions than in regions of low incidence, more tuberculosis (TB) cases due to reinfection could be expected in high-incidence regions than in low-incidence regions. Empirical data from regions with various incidence rates appear to confirm the conjecture that, in fact, the incidence rate due to reinfection only, as a proportion of all cases, correlates with the logarithm of the incidence rate, rather than with the incidence rate itself. A theoretical model that supports this conjecture is presented. A Markov model was used to obtain a relationship between incidence and reinfection rates. It was assumed in this model that the rate of reinfection is a multiple, rho (the reinfection factor), of the rate of first-time infection, lambda. The results obtained show a relationship between the proportion of cases due to reinfection and the rate of incidence that is approximately logarithmic for a range of values of the incidence rate typical of those observed in communities across the globe. A value of rho is determined such that the relationship between the proportion of cases due to reinfection and the logarithm of the incidence rate closely correlates with empirical data. From a purely theoretical investigation, it is shown that a simple relationship can be expected between the logarithm of the incidence rates and the proportions of cases due to reinfection after a prior episode of TB. This relationship is sustained by a rate of reinfection that is higher than the rate of first-time infection and this latter consideration underscores the great importance of monitoring recovered TB cases for repeat disease episodes, especially in regions where TB incidence is high. Awareness of this may assist in attempts to control the epidemic.

Entities:  

Mesh:

Year:  2009        PMID: 18577502      PMCID: PMC2610322          DOI: 10.1098/rsif.2008.0184

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  18 in total

1.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

Authors:  A van Rie; R Warren; M Richardson; T C Victor; R P Gie; D A Enarson; N Beyers; P D van Helden
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

Review 2.  The search for a tuberculosis vaccine: an elusive quest?

Authors:  Nico J D Nagelkerke; Sake J de Vlas; Yodi Mahendradhata; Tom H M Ottenhoff; Martien Borgdorff
Journal:  Tuberculosis (Edinb)       Date:  2005-10-25       Impact factor: 3.131

3.  Drug resistance in tuberculosis--a reinfection model.

Authors:  Paula Rodrigues; M Gabriela M Gomes; Carlota Rebelo
Journal:  Theor Popul Biol       Date:  2006-10-26       Impact factor: 1.570

4.  Predicting reinfection in tuberculosis.

Authors:  Paul D van Helden; Robin M Warren; Pieter Uys
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

5.  Why do symptomatic patients delay obtaining care for tuberculosis?

Authors:  S Asch; B Leake; R Anderson; L Gelberg
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

Review 6.  Exogenous reinfection in tuberculosis.

Authors:  Chen-Yuan Chiang; Lee W Riley
Journal:  Lancet Infect Dis       Date:  2005-10       Impact factor: 25.071

7.  Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis.

Authors:  Suzanne Verver; Robin M Warren; Nulda Beyers; Madalene Richardson; Gian D van der Spuy; Martien W Borgdorff; Donald A Enarson; Marcel A Behr; Paul D van Helden
Journal:  Am J Respir Crit Care Med       Date:  2005-04-14       Impact factor: 21.405

Review 8.  Prediction of the tuberculosis reinfection proportion from the local incidence.

Authors:  Jann-Yuan Wang; Li-Na Lee; Hsin-Chih Lai; Hsiao-Leng Hsu; Yuang-Shuang Liaw; Po-Ren Hsueh; Pan-Chyr Yang
Journal:  J Infect Dis       Date:  2007-06-04       Impact factor: 5.226

9.  Patients with active tuberculosis often have different strains in the same sputum specimen.

Authors:  Robin M Warren; Thomas C Victor; Elizabeth M Streicher; Madalene Richardson; Nulda Beyers; Nicolaas C Gey van Pittius; Paul D van Helden
Journal:  Am J Respir Crit Care Med       Date:  2003-12-30       Impact factor: 21.405

Review 10.  Tuberculosis due to multiple strains: a concern for the patient? A concern for tuberculosis control?

Authors:  Marcel A Behr
Journal:  Am J Respir Crit Care Med       Date:  2004-03-01       Impact factor: 21.405

View more
  17 in total

1.  How host heterogeneity governs tuberculosis reinfection?

Authors:  M Gabriela M Gomes; Ricardo Aguas; João S Lopes; Marta C Nunes; Carlota Rebelo; Paula Rodrigues; Claudio J Struchiner
Journal:  Proc Biol Sci       Date:  2012-02-22       Impact factor: 5.349

Review 2.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

Review 3.  Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'.

Authors:  D W Dowdy; C Dye; T Cohen
Journal:  Int J Tuberc Lung Dis       Date:  2013-07       Impact factor: 2.373

Review 4.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

5.  Older age at first tuberculosis diagnosis is associated with tuberculosis recurrence in HIV-negative persons.

Authors:  Y F van der Heijden; F Karim; T Chinappa; G Mufamadi; L Zako; B E Shepherd; F Maruri; M-Y S Moosa; T R Sterling; A S Pym
Journal:  Int J Tuberc Lung Dis       Date:  2018-08-01       Impact factor: 2.373

6.  Modeling the impact of early therapy for latent tuberculosis patients and its optimal control analysis.

Authors:  S Mushayabasa; C P Bhunu
Journal:  J Biol Phys       Date:  2013-08-23       Impact factor: 1.365

7.  Assessing the effects of multiple infections and long latency in the dynamics of tuberculosis.

Authors:  Hyun M Yang; Silvia M Raimundo
Journal:  Theor Biol Med Model       Date:  2010-11-08       Impact factor: 2.432

8.  Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status.

Authors:  Robin Wood; Stephen D Lawn; Judy Caldwell; Richard Kaplan; Keren Middelkoop; Linda-Gail Bekker
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

9.  The rate of sputum smear-positive tuberculosis after treatment default in a high-burden setting: a retrospective cohort study.

Authors:  Florian M Marx; Rory Dunbar; Donald A Enarson; Nulda Beyers
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

10.  Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependent.

Authors:  Madeleine Hanekom; Elizabeth M Streicher; Doreen Van de Berg; Helen Cox; Cheryl McDermid; Marlein Bosman; Nicolaas C Gey van Pittius; Tommie C Victor; Martin Kidd; Dick van Soolingen; Paul D van Helden; Robin M Warren
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.